The reactions of glycine hydroxamic and DL alanine hydroxamic acids with triacetonamine are chemoselective and afford 1 hydroxy 7,7,9,9 tetramethyl 1,4,8 triazaspiro[4.5]decan 2 one (3) and (±) 1 hydroxy 3,7,7,9,9 pentamethyl 1,4,8 triazaspiro[4.5]decan 2 one (4), re spectively. The X ray diffraction study showed that compound 3 crystallizes as a solvate with MeCN (1 : 1). As shown by ESR measurements, spiro hydroxamic acids 3 and 4 are NO donors in in vitro biological systems. The NO donor activity of compounds 3 and 4 was found to be substantially higher in the presence of DMSO. Homologue 4 is a stronger NO donor than 3. Compound 4 also exhibits high antimetastatic activity (81%) on the B16 melanoma model.